Democratic senators have introduced a new bill to create a federal regulatory framework for hemp-derived cannabinoids and ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...

Ever wonder why raspberry-flavored candy is almost always bright blue? It's a strange choice, isn't it? Real raspberries are ...

New investigational data from Phase 1/2 study of enzomenib (DSP-5336) in patients with relapsed/refractory acute myeloid leukemia (AML) show clinical ...

We may receive a commission on purchases made from links. We know there are many temptations when looking at vintage dishware in a thrift store, but there are lots of reasons you shouldn't take some ...

The FDA's proposed rule would require food manufacturers to put "Nutrition Info" boxes on the front of their packages stating ...

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...

As families prepare for the holiday season, the Food and Drug Administration (FDA) on Friday urged consumers to carefully ...

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...

UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...